An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, according to new investigations.
Experimental Drug Acquiring Popularity Online
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to message these profiles privately for supplier links, while also receiving promotional offers.
Thriving Commerce on Social Networks
Additionally, a robust trade exists on messaging services, where groups with thousands of participants share comparison images, injection guides and claims of next-day British shipping. Vendors promote the drug there before redirecting customers to WhatsApp for purchases.
Learning About Retatrutide
This medication is an experimental injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could assist patients reduce up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Voice Concerns
However, physicians and pharmacists have warned that the distribution of what is still an unapproved drug in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.
Some professionals stated the popularity for retatrutide could be connected to the increasing price of approved slimming treatments such as Mounjaro.
Legal Status and Enforcement
Marketing the unapproved drug on social media or Telegram is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the British medical regulations.
Several influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still breach pharmaceutical, advertising, and customer laws, risking penalties, legal action or imprisonment.
Platform Response and Content Removal
Based on the social media company, the service has taken down violative material and banned related keywords and search suggestions. The company said it was committed to maintaining the platform safe and allocating resources in strengthening enforcement strategies.
Digital Trading Operations
Investigations also found communities with up to 9,000 members marketing the experimental drug using Telegram's built-in discovery tool, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, filled with photos of slimming results, positive testimonials and detailed instructions for mixing or injecting at home.
After minutes of joining one group, a vendor shared WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about body mass, health issues or past usage.
Product Details and Pricing
Inside these groups, messages show dark colored parcels with Royal Mail stickers, claiming to contain fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can select between dry substance containers, prepared at home with purified liquid, or ready-to-use pens usually priced at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.
Platform Oversight and Security Actions
A spokesperson for the messaging service stated it regularly monitored dangerous material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering substances they cannot confirm. Even if the science behind this drug is valid, these digital products may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of Asda Online Doctor connected the increase in interest to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were made in was clean,” she explained.
Her staff has previously encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from Telegram or communication platforms is taking chances with your health,” stated the doctor. “These substances could be contaminated or improperly measured.”
Producer Position
A spokesperson from Eli Lilly stated retatrutide was in phase 3 clinical trials and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company experimental substance not yet approved … may expose patients to possibly serious health risks”.
